MiNK Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INKT and other ETFs, options, and stocks.About INKT
MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded by Garo H.
INKT Key Statistics
Stock Snapshot
As of today, MiNK Therapeutics(INKT) shares are valued at $10.50. The company's market cap stands at 52.56M, with a P/E ratio of -3.72.
As of 2026-07-09, MiNK Therapeutics(INKT) stock has fluctuated between $10.50 and $11.23. The current price stands at $10.50, placing the stock +0.0% above today's low and -6.5% off the high.
The MiNK Therapeutics(INKT)'s current trading volume is 12.08K, compared to an average daily volume of 14.03K.
In the last year, MiNK Therapeutics(INKT) shares hit a 52-week high of $76.00 and a 52-week low of $7.28.
In the last year, MiNK Therapeutics(INKT) shares hit a 52-week high of $76.00 and a 52-week low of $7.28.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.